Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

Rimner A, Zauderer MG, Gomez DR, Adusumilli PS, Parhar PK, Wu AJ, Woo KM, Shen R, Ginsberg MS, Yorke ED, Rice DC, Tsao AS, Rosenzweig KE, Rusch VW, Krug LM.

J Clin Oncol. 2016 Aug 10;34(23):2761-8. doi: 10.1200/JCO.2016.67.2675. Epub 2016 Jun 20.

2.

Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma.

Barker CA, Postow MA, Khan SA, Beal K, Parhar PK, Yamada Y, Lee NY, Wolchok JD.

Cancer Immunol Res. 2013 Aug;1(2):92-8. doi: 10.1158/2326-6066.CIR-13-0082. Epub 2013 Jul 25. Review.

3.

Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas.

Parhar PK, Duckworth T, Shah P, DeWyngaert JK, Narayana A, Formenti SC, Shah JN.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):379-84. doi: 10.1016/j.ijrobp.2009.07.1695. Epub 2009 Dec 16.

PMID:
20015598
4.

Pharmacogenomics and breast cancer.

Lymberis SC, Parhar PK, Katsoulakis E, Formenti SC.

Pharmacogenomics. 2004 Jan;5(1):31-55. Review.

PMID:
14683419

Supplemental Content

Loading ...
Support Center